← Open Payments lookup

CINDY HOPKINS: Open Payments

NPI 1508426693 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,386 in 64 payments from 23 companies in 2025. Trend: 2023 $16 · 2024 $948 · 2025 $1,386

Food & beverage: $1,386
CompanyPaymentsAmount
Novo Nordisk Inc6$202
Lilly USA, LLC10$165
Corcept Therapeutics4$146
ABBVIE INC.2$144
PFIZER INC.7$117
GlaxoSmithKline, LLC.7$114
Axsome Therapeutics, Inc.3$66
Amgen Inc.3$45
Phathom Pharmaceuticals, Inc.3$44
AstraZeneca Pharmaceuticals LP3$43

Products named: Ozempic, Korlym, QULIPTA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Auvelity, NURTEC ODT.

Industry payments across TX — which companies pay providers there.